Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KBTBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACVR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC441178 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
EARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BACE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CGB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100268168 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYNC2LI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACVR2B-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC284561 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on